SKWD Skyward Specialty Insurance Gro
$59.43▲ +1.58%
Financials
Other
Volume 96.5K
Avg Volume (10D) 309.0K
Key Metrics & Fundamentals
Market Cap
$2.64B
P/E Ratio
13.8
Div Yield
0.00%
52W Range
40.60 - 65.69
% vs 50 MA
1.73%
% vs 200 MA
13.56%
RSI-14
49.0
MACD Histogram
-0.2600
Beta (1Y vs SPY)
0.01
Free Cash Flow
-$236.37M
Gross Rev
$490.59M
Gross Profit
$490.59M
EBITDA
–
COGS
–
Operating Exp
–
Operating Income
–
EBIT
–
Pretax Income
$63.56M
Net Income
$49.04M
EPS (Diluted)
1.07
Price & Volume History
Loading chart…
Recent News

Essent Group (ESNT) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
Zacks · Oct 30, 2026 9:00 AM ET

Skyward Specialty Insurance (SKWD) Earnings Expected to Grow: Should You Buy?
Zacks · Oct 29, 2026 9:00 AM ET

3 market-beating stocks to consider right now
StockStory · Oct 29, 2026 3:55 AM ET

Hope Bancorp (HOPE) Q3 Earnings Lag Estimates
Zacks · Oct 28, 2026 8:30 AM ET
Skyward Specialty Insurance Signs on as Slingshot Insurance's Primary Carrier Partner
MT Newswires · Oct 27, 2026 10:26 AM ET

CNO Financial to Report Q3 Earnings: What Should We Expect?
Zacks · Oct 27, 2026 8:44 AM ET

Slingshot Insurance and Skyward Group Partner to Accelerate Growth in Embedded Insurance
PR Newswire · Oct 27, 2026 8:00 AM ET

Insurance Name Shines As Investors Play Defense In Uncertain Market
Investor's Business Daily · Oct 23, 2026 1:58 PM ET

Can AON Beat on Q3 Earnings Despite Weakness in Wealth Solutions?
Zacks · Oct 23, 2026 7:16 AM ET

Selective Insurance (SIGI) Q3 Earnings Top Estimates
Zacks · Oct 22, 2026 5:00 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See SKWD's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.